Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-02T20:00:00.014Z Has data issue: false hasContentIssue false

Varenicline-Induced Psychosis

Published online by Cambridge University Press:  07 November 2014

Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters
Copyright
Copyright © Cambridge University Press 2010

References

1. Champix: Prospektus ozeti. Available at: http//champix.com.tr. Accessed September 08, 2009.Google Scholar
2. FDA approves novel medication for smoking cessation. Available at: http//fda.gov/NewsEvents/NewsroomPressAnnouncements/2006/ucm108651.htm. Accessed September 08, 2009.Google Scholar
3.Kaur, K, Kaushal, S, Chopra, SC. Varenicline for smoking cessation: a review of the literature. Curr Ther Res Clin Exp. 2009;70:3554.CrossRefGoogle ScholarPubMed
4.Ziedonis, D, Hitsman, B, Beckham, JC, et al. Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine Tob Res. 2008;10(12):16911715.CrossRefGoogle ScholarPubMed
5.Cahill, K, Stead, LF, Lancaster, T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2008;16(3):CD006103.CrossRefGoogle Scholar
6. Chantix (Varenicline) tablets. Important Safety Information. Available at: http//chatix.com/side-effects-safety-info.aspx. Accessed September 09, 2009.Google Scholar
7.Kintz, P, Evans, J, Villain, M, Cirimele, V. Smoking cessation with varenicline: a suicidal fatality. J Anal Toxicol. 2009;33:118120.CrossRefGoogle ScholarPubMed
8.Stapleton, J. Do the 10 UK suicides among those taking the smoking cessation drug varenicline suggest a causal link? Addiction. 2009;104(5):864865.CrossRefGoogle ScholarPubMed
9.Kohen, I, Kremen, N. Varenicline-induced manic episode in a patient with bipolar disorder [letter]. Am J Psychiatry. 2007;164:12691270.CrossRefGoogle Scholar
10.Popkin, MK. Exacerbation of recurrent depression as a result of treatment with varenicline [letter]. Am J Psychiatry. 2008;165:6.CrossRefGoogle ScholarPubMed
11.Lyon, G J. Possible varenicline-induced paranoia and irritability in a patient with major depressive disorder, borderline personality disorder, and methamphetamine abuse in remission [letter]. J Clin Psychopharmacol. 2008;28(6):720721.CrossRefGoogle Scholar
12.Morstad, AE, Kutscher, EC. Hypomania with agitation associated with varenicline use in bipolar II disorder [letter]. Ann Pharmacother. 2008;42:288.CrossRefGoogle ScholarPubMed
13.Liu, ME, Tsai, SJ, Yang, ST. Varenicline-induced mixed mood and psychotic episode in a patient with schizoaffective disorder [letter]. CNS Spectr. 2009;14(7):346.CrossRefGoogle Scholar
14.Alhatem, F, Black, JE. Varenicline-induced mania in a bipolar patient. Clin Neuropharm. 2009;32:117118.CrossRefGoogle Scholar
15.Freedman, R. Exacerbation of schizophrenia by varenicline [letter]. Am J Psychiatry. 2007;164:1269.CrossRefGoogle ScholarPubMed
16.Pumariega, AJ, Nelson, R, Rotenberg, L. Varenicline induced mixed mood and psychotic episode in a patient with a past history of depression. CNS Spectr. 2008;13(6):511514.CrossRefGoogle Scholar
17.Food and Drug Administration. Important Information on Chantix ( Varenicline). Available at: http://www.fda.gov/Drugs/Drugsafety/PublicHealthAdvisories/UCM051136. Accessed September 08, 2009.Google Scholar
18.Naranjo, CA, Busto, U, Sellers, EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239245.CrossRefGoogle ScholarPubMed
19.Fatemi, SH. Varenicline efficacy and tolerability in a subject with schizophrenia [letter]. Schizophr Res. 2008;103:328329.CrossRefGoogle Scholar
20.Evins, AE, Goff, DC. Varenicline treatment for smokers with schizophrenia: a case series [letter]. J Clin Psychiatry. 2008;69(6):1016.CrossRefGoogle ScholarPubMed
21.Ochoa, E. Varenicline reduced smoking behaviour in a mentally ill person [letter]. J Psychopharmacol. 2009;23(3):340341.CrossRefGoogle Scholar
22.Stapleton, JA, Watson, L, Spirling, LI, et al. Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness. Addiction. 2007;103:146154.CrossRefGoogle Scholar
23.Smith, RC, Lindenmayer, JP, Davis, JM, et al. Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder. Schizophr Res. 2009; 110: 149155.CrossRefGoogle ScholarPubMed
24.Patterson, F, Jepson, C, Strasser, AA, et al. Varenicline improves mood and cognition during smoking abstinence. Biol Psychiatry. 2009; 65(2): 144149.CrossRefGoogle ScholarPubMed
25.Hughes, JR, Higgins, ST, Bickel, WK. Nicotine withdrawal versus other withdrawal syndromes: similarities and dissimilarities. Addiction. 1994; 89: 14611470.CrossRefGoogle ScholarPubMed
26.Hughes, RH. Smoking and suicide: a brief overview. Drug Alcohol Depend. 2008; 98: 169178.CrossRefGoogle ScholarPubMed